Abstract. Using a combined infusion of somatostatin, insulin and glucose, insulin resistance was assessed in vivo in two groups of females with polycystic ovaries (PCO), obese (OB-PCO) and normal weight (NO-PCO) 
glucose (SSPG) and insulin (SSPI) was attained after 90 min. OB-PCO and NO-PCO showed higher SSPG with respect to matched controls. The SSPG levels were related to body mass index (r = 0.69; P < 0.001). The SSPG values were significantly correlated with the fasting insulin levels (r = 0.47; P < 0.003). Gonadotrophin and steroid peripheral blood concentrations were also evaluated in the PCO females. A significant correlation was found between the SSPG values and the dehydroepiandrosterone sulphate levels (r = 0.46; P < 0.05) and between the fasting insulin levels and the androstenedione concentrations (r = 0.64; P <0. 01). 0.01). Moreover, significant correlation coefficients were found between the glucose to insulin ratio and the A (r = \p=n-\0.59; P < 0.01) and the DHEA-S (r = \p=n-\0.50; P <0.05) plasma levels. Finally, no relationship between body mass index and A or DHEA-s levels was found in PCO females considered as a group. We conclude that insulin resistance is present in females with PCO and it is mainly dut to the presence of obesity, but other factors such as androgen levels, probably of adrenal sources, must be considered as a cause.
Patients with polycystic ovaries (PCO) and obesity, commonly present high blood insulin levels and a condition of insulin resistance (Burghen et al. 1980; Pasquali et al. 1982) . Moreover, in a previous study, we found that PCO obese patients had higher glucose-stimulated C-peptide levels when compared to a matched group of obese females, suggesting a more increased activity of the ß-cell after glucose stimulation, than that found in obes¬ ity itself (Pasquali et al. 1982) . Possible (Paradisi et al. 1980 ), using antisera made in our laboratory (Cacciari et al. 1974 found between obese and non-obese groups.
As depicted in Fig. 2 (Fig. 3) . A significant correlation between BMI and SSPG values was also present when obese females (OB-PCO and OB) were considered separately (r = 0.56; < 0.01).
For the purpose of this study, only gonadotro¬ phin and steroid blood levels in PCO patients will be discussed. LH plasma concentrations were signi¬ ficantly higher (P < 0.04) in NO-PCO (38.5 ± 6.3 mU/ml) with respect to values found in OB-PCO (24.4 ± 3.6 mU/ml) (in our laboratory, normal range in the follicular phase is 5.1-13.8 mU/ml). No differences were found in FSH plasma levels (OB-PCO: 9.6 ± 1.0 mU/ml; NO-PCO: 9.9 ± 1.0 mU/ml; = ns). Values (Fig. 4 ) and the E2:Ei ratio (r = -0.49; < 0.05). The fasting glucose: insulin ratio was significantly correlated with A (r=-0.59; < 0.01) (Fig. 4) , DHEA-S (r = -0.50; < 0.05) (Fig. 4) (Fig. 4) . (Yen 1980) . On the other hand, circulating levels of DHEA and its sulphate in these patients have been shown to be principally secreted by the adrenal gland, while A levels are probably of combined ovarian and adrenal sources (Yen 1980; Abraham 1975) . Moreover, in patients with PCO, the pre¬ sence of mild adrenal hyperplasia has been esta¬ blished (Yen 1980; Kandeel et al. 1980 ). The effect of increased body weight may obviously be of importance, particularly with regard to DHEA and DHEA-S dynamic. Obesity may also account for an increased conversion of A to Ei (Siiteri & Mac Donald 1973; Edman & MacDonald 1978) , in addition to PCO itself (Yen 1980) . This fact could explain why OB-PCO females had higher values of Ei levels when compared to NO-PCO subjects. In fact, in normal weight and obese PCO patients, we found that the E2:Ei ratio was closely related to BMI, as well as to the parameters of ß-cell activity. These findings suggest that obesity per se, inde¬ pendent of the presence of PCO, is probably the major factor in the control of peripheral oestrogen production.
Further studies are needed to establish whether these hormonal conditions are of physio-patholo¬ gical importance in the development of PCO, espe¬ cially in young obese girls.
